Search clinical trials for: Apixaban 2.5 milligram

Total 4605 results

USDA Beltsville Human Nutrition Research Center
Penn State University

Completed

The Dose-Response Effects of Lean Beef in a Mediterranean-Style Dietary Pattern on Cardiovascular Disease Risk Factors

Healthy Volunteers

United States
McMaster University

Completed

Improved Adherence With Extended Venous Thromboembolism Prophylaxis After Major Cancer Surgery

Surgery | Venous Thromboembolism | Adherence, Medication | Prophylaxis | Neoplasms Malignant

Canada
Region Stockholm
Uppsala University

Recruiting

Stroke Prophylaxis With Apixaban in Chronic Kidney Disease Stage 5 Patients With Atrial Fibrillation (SACK)

Stroke | Chronic Kidney Diseases | Death | Atrial Fibrillation | Intracerebral Hemorrhage | Kidney Transplant; Complications | Thromboses, Venous | Cardiovascular Complication | Major Bleed

Sweden, Norway, Iceland, Finland
Boehringer Ingelheim

Completed

A Study in Healthy Men to Test How Different Doses of BI 474121 Are Taken up and How They Influence the Amount of a Molecular Messenger (cGMP) in the Spinal Fluid

Healthy

Netherlands
Hospital Universitari de Bellvitge
Baxter Healthcare Corporation; Spanish Society of Nephrology

Completed

Study of Apixaban in Patients Receiving Hemodiafiltration (HEMOCIONA)

Atrial Fibrillation | Hemodialysis Complication

Spain
McMaster University

Recruiting

Postoperative Extended Venous Thromboprophylaxis in Inflammatory Bowel Disease (EXPAND)

Crohn Disease | Ulcerative Colitis | Venous Thromboembolism | Colorectal Disorders | Pulmonary Embolism | IBD

Canada
Biozeus Biopharmaceutical S.A.

Not yet recruiting

Evaluation of the Efficacy, Safety and Tolerability of BZ371A in Women With Sexual Arousal Disorder

Female Sexual Dysfunction | Female Sexual Arousal Disorder
PharmaMar
Apices Soluciones S.L.

Completed

Extension Study in a Cohort of Adult Patients With COVID-19 Infection (E-APLICOV-PC)

COVID-19 Infection

Spain
Alexandria University

Completed

Effect of Hepatitis C Clearance on Insulin Resistance

Hepatitis C | Insulin Resistance

Egypt
GlaxoSmithKline

Completed

Phase 2, Pharmacokinetics Study of Eltrombopag in Japanese Thrombocytopenic Subjects With Chronic Liver Disease

Liver Diseases

Japan
Claret Medical
Meditrial Europe Ltd.

Completed

Carotid Filtration During Endovascular Aortic Valve Implantation

Heart Diseases
Assistance Publique - Hôpitaux de Paris
Bristol-Myers Squibb

Active, not recruiting

API-CAT STUDY for APIxaban Cancer Associated Thrombosis (API-CAT)

Cancer-associated Thrombosis

France, Spain, Netherlands, Belgium, Austria, Greece, Switzerland, Canada, Italy, Poland, United Kingdom
University of Michigan Rogel Cancer Center
Rush University Medical Center

Completed

Dose-Escalation Study of Intensity-Modulated Radiotherapy(IMRT)in Patients With Unresectable Pancreatic Cancer

Pancreatic Cancer

United States
Hennepin Healthcare Research Institute
National Institute of Neurological Disorders and Stroke (NINDS); Strategies...

Recruiting

Hyperbaric Oxygen Brain Injury Treatment Trial (HOBIT)

Traumatic Brain Injury

United States, Canada
Biolux Research Holdings, Inc.

Unknown

OrthoPulse 2.0 and 2.1 Feasibility Evaluation (BX13)

Malocclusion

United States, Canada
The First Affiliated Hospital of Guangzhou Medical...
Sinotau Pharmaceutical Group

Completed

Study of 64Cu-FAPI-XT117 PET/CT in Patients With Malignant Solid Tumors

Malignant Solid Tumors

China
Radiation Therapy Oncology Group
National Cancer Institute (NCI)

Completed

Brain Irradiation in Treating Patients With Limited-Stage Small Cell Lung Cancer

Lung Cancer

United States, Canada
University Hospital, Geneva
Sunnybrook Health Sciences Centre

Not yet recruiting

The API-CALF Study: Apixaban to Treat Calf Vein Thrombosis (API-CALF)

Deep Vein Thrombosis
Instituto de Investigacion Sanitaria La Fe
Bristol-Myers Squibb

Terminated

Prophylaxis With Apixaban in Transplant Eligible Patients With Multiple Myeloma Receiving Induction Therapy With IMiDs

Venous Thromboembolism

Spain
Brazilian Clinical Research Institute
Hospital Israelita Albert Einstein; Hospital Moinhos de Vento; Hospital do Coracao and other collaborators

Terminated

Apixaban for PrOphyLaxis of thromboemboLic Outcomes in COVID-19 (APOLLO)

Covid19 | Thrombosis

Brazil
Janssen Pharmaceutical K.K.

Completed

Pharmacokinetic Study of JNJ-56021927 When Taken Orally as Tablet Formulation in Healthy Male Japanese Participants

Healthy

Japan
Thomas L. Ortel
National Heart, Lung, and Blood Institute (NHLBI)

Completed

COVID-19 Thrombosis Prevention Trials: Post-hospital Thromboprophylaxis

Covid19

United States
RemeGen Co., Ltd.

Completed

A Study of RC48-ADC in Subjects With Advanced Breast Cancer

Advanced Breast Cancer

China
Assistance Publique - Hôpitaux de Paris

Not yet recruiting

DIrect Oral Anticoagulation and mechaNical Aortic Valve (DIAMOND)

Aortic Valve Disease

France
Carina Biotech Limited

Recruiting

A Study of CNA3103 (LGR5-targeted, Autologous CAR-T Cells) Administered to Subjects With Metastatic Colorectal Cancer

Colorectal Cancer Metastatic

Australia
Tulane University
Louisiana State University Health Sciences Center in New Orleans; Antares Pharma...

Not yet recruiting

Testosterone Treatment for Erectile Dysfunction and Multiple Sclerosis

Multiple Sclerosis | Erectile Dysfunction | Testosterone Deficiency

United States
AZ Sint-Jan AV

Completed

Catheter Ablation of All Inducible AT Post AF Ablation (INDUCATH)

Atrial Fibrillation | Atrial Tachycardia

France, Belgium, Germany, United Kingdom
National Taiwan University Hospital Hsin-Chu Branch

Unknown

Apixaban for Prevention of Post-angioplasty Thrombosis of Hemodialysis Vascular Access

Hemodialysis Access Failure

Taiwan
Artivion Inc.
Duke Clinical Research Institute

Terminated

PROACT Xa - A Trial to Determine if Participants With an On-X Aortic Valve Can be Maintained Safely on Apixaban

Aortic Valve Stenosis | Aortic Valve Disease | Aortic Valve Failure

United States
Brigham and Women's Hospital

Active, not recruiting

Extended-Duration Low-Intensity Apixaban to Prevent Recurrence in High-Risk Patients With Provoked Venous Thromboembolism (HI-PRO)

Deep Vein Thrombosis | Venous Thromboembolism | Pulmonary Embolism

United States
Hamilton Health Sciences Corporation
University Health Network, Toronto; Dartmouth-Hitchcock Medical Center; Ottawa... and other collaborators

Terminated

Strategies for Transfusion of Platelets (SToP)

Thrombocytopenia

United States, Norway, Canada
Iperboreal Pharma Srl

Recruiting

Efficacy and Safety of XyloCore Peritoneal Dialysis Solution. (ELIXIR)

End Stage Renal Disease

Denmark, Sweden, Italy, Spain, United Kingdom, Germany
Notal Vision Ltd.
Elman Retina Group

Completed

NOTAL-OCT V.2.5 vs Commercial OCT in AMD Patients

Diabetic Macular Edema | AMD - Age-Related Macular Degeneration

United States
Almond Board of California
KGK Science Inc.

Completed

Investigating the Dose Response of an Almond-enriched Diet on Optimizing HDL-C in a Population With Hypercholesterolemia

Hypercholesterolemia | HDL-C

Canada
GlaxoSmithKline

Completed

A New Oral Treatment For Type II Diabetes Mellitus

Diabetes Mellitus, Type 2

United States, Germany, Canada, Sweden, Latvia, Finland, Greece, Romania, Czechia, Puerto Rico
Novartis Vaccines

Completed

Safety and Immunogenicity of a Group B Streptococcus Vaccine in Non Pregnant and Pregnant Women 18-40 Years of Age

Streptococcal Infections

South Africa
GlaxoSmithKline

Completed

Single Dose Study of Controlled-Release Paroxetine Tablets in Healthy Japanese Male Subjects

Depressive Disorder

Japan
Cairo University
Norhan Abdel Aleem Ali; Hagar hassanein refaee; Ahmed Abdullah Fathi Mohamed...

Completed

A Comparative Study on Three Different Doses of Intrathecal Hyperbaric Prilocaine With Fentanyl for Optimal Dose to be Used in Elderly Patients Undergoing Day Case Lower Abdominal and Urologic Surgeries.

Three Different Doses of Intrathecal Hyperbaric Prilocaine With Fentanyl

Egypt
Duke University
Patient-Centered Outcomes Research Institute

Terminated

Comparison of Oral Anticoagulants for Extended VEnous Thromboembolism (COVET)

Venous Thromboembolism

United States
CSPC Baike (Shandong) Biopharmaceutical Co., Ltd.

Not yet recruiting

A Study of TG103 Injection in the Management of Non-diabetic Overweight or Obesity

Obesity | Overweight
Guangdong Zhongsheng Pharmaceutical Co., Ltd.

Completed

Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Single Ascending Dose of ZSP1603 in Healthy Adults

Solid Tumor | Idiopathic Pulmonary Fibrosis(IPF)

China
GlaxoSmithKline

Completed

A Study to Evaluate the Safety and Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of Melrilimab (GSK3772847) in Healthy Participants

Asthma | Healthy Volunteers

United States
CORTESI LAURA

Unknown

Phase 2 Study of Pembrolizumab+Carboplatin in Breast Related Cancer Antigens-related Metastatic Breast Cancer (PEMBRACA)

Metastatic Breast Cancer
Eisai Inc.

Completed

A Two-Part Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of E2006 in Healthy Japanese and White Subjects

Healthy Volunteers

United States
Stanford University

Recruiting

Apixaban vs Enoxaparin Following Microsurgical Breast Reconstruction-An RCT

Venous Thromboembolism

United States
Pfizer
Bristol-Myers Squibb

Completed

Bioavailability Study Comparing Modified Release To Immediate Release Apixaban Tablets In Healthy Volunteers

Thrombosis

United States
Janssen Research & Development, LLC

Completed

A Safety, Tolerability and Pharmacokinetics Study of a Single Intravenous Dose of JNJ-49122944 in Healthy Male Participants

Healthy

Belgium
Bioverativ, a Sanofi company

Completed

A Study to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple- Dose BIVV009 in Participants With Chronic Immune Thrombocytopenia (ITP)

Purpura, Thrombocytopenic, Idiopathic

United Kingdom, United States, Germany
Novo Nordisk A/S

Completed

A Research Study to Investigate How Well NNC0165-1875 in Combination With Semaglutide Works in People With Obesity

Obesity

United States
University Hospital Inselspital, Berne
Centre Hospitalier Universitaire Vaudois

Recruiting

Direct Oral Anticoagulants (Rivaroxaban and Apixaban) in Patients With Liver Cirrhosis

Liver Cirrhosis

Switzerland

Search clinical trials for: Apixaban 2.5 milligram

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Argentina

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations